360 NEWS360 NEWS

Business · National

Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval

Lilly plans to file by the end of the year for U.S. approval of the daily pill for moderate-to-severe obstructive sleep apnea in adults with obesity.

Verified Timeline

No verified timeline updates.

Voluntary Reader Opinion

What is your view on “Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval”?

This is self-selected reader participation, not representative scientific polling.